Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases

Go back to Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases
(NASDAQ: JAGX) Delayed: 2.55 -0.06 (2.3%)
Previous Close $2.61    52 Week High $4.60 
Open $2.50    52 Week Low $0.81 
Day High $2.64    P/E N/A 
Day Low $2.46    EPS $0.00 
Volume 86,753